Boston Scientific (BSX) Gross Profit (2009 - 2026)

Boston Scientific has disclosed Gross Profit across 18 years of filings, most recently posting $3.8 billion for Q2 2026.

• In Q2 2026, Gross Profit rose 12.38% year-over-year to $3.8 billion; the TTM figure through Jun 2026 stood at $14.7 billion (up 16.29% YoY), while the FY2025 annual figure was $13.9 billion, up 20.57% from the prior year.
• Gross Profit came in at $3.8 billion for Q2 2026 at Boston Scientific, up from $3.6 billion in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $3.8 billion in Q2 2026 to a low of $2.1 billion in Q1 2022.
• Average Gross Profit over 5 years is $2.9 billion, with a median of $2.7 billion recorded in 2024.
• Year-over-year, Gross Profit grew 3.57% in 2022 and rose 22.26% in 2025.
• Over 5 years, Gross Profit stood at $2.2 billion in 2022, then grew by 15.55% to $2.6 billion in 2023, then gained by 20.01% to $3.1 billion in 2024, then advanced by 18.87% to $3.7 billion in 2025, then advanced by 4.59% to $3.8 billion in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $3.8 billion in Q2 2026, $3.6 billion in Q1 2026, and $3.7 billion in Q4 2025.